Largest-Ever Funding Round Paves the Way for AI-driven Dentistry
Overjet, a pioneer in dental artificial intelligence, has announced a groundbreaking $53.2 million Series C funding round, marking the largest investment in AI for dentistry. The investment, spearheaded by March Capital, with significant contributions from General Catalyst, Insight Partners, and other major players, brings Overjet’s total funding to approximately $133 million and elevates the company’s valuation to an impressive $550 million.
Revolutionizing dentistry with AI
Since its inception in 2018, Overjet has been dedicated to revolutionizing dentistry by leveraging cutting-edge AI technology. The company’s mission is to prioritize patient-centric care by equipping dental professionals with the tools to operate efficiently and deliver exceptional care.
Overjet’s platform has already set new standards in diagnosing diseases from X-rays, educating patients about their oral health, and streamlining dental insurance claims review processes.
Overjet’s rapid growth trajectory has seen the company’s platform adopted by thousands of dentists across private practices and major dental support organizations (DSOs) in North America.
Additionally, Overjet has established partnerships with key payers covering over 120 million members, including leading U.S. dental insurers. The company’s impactful contributions have earned it accolades such as inclusion in the Forbes AI 50, recognition as one of Fast Company’s World’s Most Innovative Companies, and acknowledgment as one of Built In’s Best Places to Work.
Unparalleled clinical precision and efficiency
One of Overjet’s key achievements is its FDA-cleared technology, which can detect, outline, and quantify instances of oral disease with millimeter-level precision. By providing a common language for dentists, insurers, and patients, Overjet eliminates discrepancies in interpretation, enhances communication, and reduces treatment decision uncertainty.
Clinicians using Overjet have reported increased accuracy in detecting cavities and calculus, leading to more informed treatment recommendations and higher patient acceptance rates.
Overjet’s AI is a powerful tool to augment human judgment rather than replace it. The platform enables clinicians, dental executives, administrators, and insurers to diagnose conditions, recommend care plans, review claims, and optimize business operations efficiently.
By automating workflows and improving the efficiency and quality of dental care, Overjet is spearheading a transformative shift towards a new AI-enabled standard of care within the dental industry.
Continued innovation and growth
With the Series C funding, Overjet aims to expand its market-leading AI capabilities further, focusing on eliminating friction and uncertainty for patients at every stage of their dental care journey. By seamlessly connecting the diagnosis, treatment, and claims approval processes, Overjet envisions a future where doctors and patients receive benefits decisions in real-time. At the same time, insurers enhance their member experience significantly.
To support its continued growth and innovation, Overjet has appointed several key executive leaders to its team. These include Mike Lemire as VP of Customer Success for Practice, Mario Paganini as SVP of Marketing, and Matthew Ewing as SVP of Revenue. These appointments complement Overjet’s already best-in-class clinical and technology teams, further strengthening the company’s position as a leader in dental AI.
Read More
Largest-Ever Funding Round Paves the Way for AI-driven Dentistry
Overjet, a pioneer in dental artificial intelligence, has announced a groundbreaking $53.2 million Series C funding round, marking the largest investment in AI for dentistry. The investment, spearheaded by March Capital, with significant contributions from General Catalyst, Insight Partners, and other major players, brings Overjet’s total funding to approximately $133 million and elevates the company’s valuation to an impressive $550 million.
Revolutionizing dentistry with AI
Since its inception in 2018, Overjet has been dedicated to revolutionizing dentistry by leveraging cutting-edge AI technology. The company’s mission is to prioritize patient-centric care by equipping dental professionals with the tools to operate efficiently and deliver exceptional care.
Overjet’s platform has already set new standards in diagnosing diseases from X-rays, educating patients about their oral health, and streamlining dental insurance claims review processes.
Overjet’s rapid growth trajectory has seen the company’s platform adopted by thousands of dentists across private practices and major dental support organizations (DSOs) in North America.
Additionally, Overjet has established partnerships with key payers covering over 120 million members, including leading U.S. dental insurers. The company’s impactful contributions have earned it accolades such as inclusion in the Forbes AI 50, recognition as one of Fast Company’s World’s Most Innovative Companies, and acknowledgment as one of Built In’s Best Places to Work.
Unparalleled clinical precision and efficiency
One of Overjet’s key achievements is its FDA-cleared technology, which can detect, outline, and quantify instances of oral disease with millimeter-level precision. By providing a common language for dentists, insurers, and patients, Overjet eliminates discrepancies in interpretation, enhances communication, and reduces treatment decision uncertainty.
Clinicians using Overjet have reported increased accuracy in detecting cavities and calculus, leading to more informed treatment recommendations and higher patient acceptance rates.
Overjet’s AI is a powerful tool to augment human judgment rather than replace it. The platform enables clinicians, dental executives, administrators, and insurers to diagnose conditions, recommend care plans, review claims, and optimize business operations efficiently.
By automating workflows and improving the efficiency and quality of dental care, Overjet is spearheading a transformative shift towards a new AI-enabled standard of care within the dental industry.
Continued innovation and growth
With the Series C funding, Overjet aims to expand its market-leading AI capabilities further, focusing on eliminating friction and uncertainty for patients at every stage of their dental care journey. By seamlessly connecting the diagnosis, treatment, and claims approval processes, Overjet envisions a future where doctors and patients receive benefits decisions in real-time. At the same time, insurers enhance their member experience significantly.
To support its continued growth and innovation, Overjet has appointed several key executive leaders to its team. These include Mike Lemire as VP of Customer Success for Practice, Mario Paganini as SVP of Marketing, and Matthew Ewing as SVP of Revenue. These appointments complement Overjet’s already best-in-class clinical and technology teams, further strengthening the company’s position as a leader in dental AI.
Read More